Inventaire - teman dan komunitas anda adalah perpustakaan terbaik - Inventaire

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

diterbitkan dalam: Personalized Medicine

tanggal publikasi: 2010-01-01

bahasa: Inggris

subyek utama: biomarker

Cites articles 36

Date

Judul

Pengarang

2010-08-04

A threshold sample-enrichment approach in a clinical trial with heterogeneous subpopulations

Aiyi Liu
2009-10-08

Use of archived specimens in evaluation of prognostic and predictive biomarkers
2009-01-01

Clinical trial designs for predictive biomarker validation: one size does not fit all.

Daniel J. Sargent
2008-10-07

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

John Potter, Patrick Bossuyt, Holly J. Moore, Margaret Sullivan Pepe
2008-10-01

The use of genomics in clinical trial design
2008-10-01

Validation of analytic methods for biomarkers used in drug development

Olivier Rixe
2008-07-01

Randomized phase III clinical trial designs for targeted agents

Antje Hoering
2008-04-01

The cancer biomarker problem
2008-03-03

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Marc Peeters, Salvatore Siena
2008-02-01

Development of the 21-gene assay and its application in clinical practice and clinical trials
2008-10-01

K-ras mutations and benefit from cetuximab in advanced colorectal cancer

Timothy Price, John Zalcberg
2008-06-01

Designs and adaptive analysis plans for pivotal clinical trials of therapeutics and companion diagnostics
2007-01-01

Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting
2007

Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset
2007-06-27

Biomarker-adaptive threshold design: a procedure for evaluating treatment with possible biomarker-defined subset effect.

Boris Freidlin
2007-10-11

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

Larry Norton, Gloria Broadwater, Donald L. Weaver, James N Ingle, Eric Winer
2007-08-01

A method for testing a prespecified subgroup in clinical trials
2007-06-01

Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen
2007-12-25

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials

Alessandra Gennari, Paolo Pronzato, Matteo Puntoni, Ulrich Pfeffer, Paolo Bruzzi
2006-12-11

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

Marc van de Vijver, American Society of Clinical Oncology, College of American Pathologists, Gail H. Vance, Edith A. Perez
2006-10-01

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

Marc Buyse, Sherene Loi, Fátima Cardoso, Emiel Rutgers
2006-06-01

Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer
2006-05-01

Use of genomic signatures in therapeutics development in oncology and other diseases
2005-10-18

Prognostic and predictive factors revisited
2005-05-19

Prediction error estimation: a comparison of resampling methods
2005-01-01

Clinical trial designs for prospective validation of biomarkers.

Daniel J. Sargent, Matthew P Goetz
2005-11-01

Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients
2005-02-01

On the efficiency of targeted clinical trials
2004-05-01

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

Holly J. Moore, Wendy Leisenring, Polly A Newcomb
2004-12-30

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Soonmyung Paik, Chungyeul Kim
2004-11-01

When is a genomic classifier ready for prime time?
2004-07-01

Perspectives and challenges of clinical pharmacogenomics in cancer

Artikel - wd:Q33775506

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut

anda sedang luring